Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.

Campbell, S M

Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma. [electronic resource] - The British journal of dermatology Aug 2008 - 387-93 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study

1365-2133

10.1111/j.1365-2133.2008.08668.x doi


Adult
Aged
Aged, 80 and over
Aminolevulinic Acid--therapeutic use
Carcinoma, Basal Cell--drug therapy
Dose-Response Relationship, Drug
Female
Humans
Iron Chelating Agents--adverse effects
Male
Middle Aged
Pain--etiology
Photochemotherapy--adverse effects
Photosensitizing Agents--therapeutic use
Pilot Projects
Pyridones--adverse effects
Skin Neoplasms--drug therapy
Treatment Outcome